CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,437 enrolled
Drug / intervention
Azilsartandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02092025
NCT02092025N/ACompleted
CompareCT.gov

Azilsartan Tablets Special Drug Use Surveillance: Long-term Use

Takeda·observational·Posted Mar 19, 2014·Updated Jan 15, 2019

In Brief

An observational study evaluating Azilsartan for Hypertension. Completed, enrolled 3,437 participants across 2 sites.

Detailed Summary

The purpose of this survey is to evaluate the safety and efficacy of long-term use of azilsartan tablets (Azilva Tablets) in patients with hypertension in a routine clinical setting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 19, 2014
Enrollment StartJun 20, 2012
Primary CompletionJan 15, 2016
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 12.3 years ago

Interventions

Azilsartandrug

Azilsartan tablets